Product Name | Tesirine | SG3249 |
---|---|
CAS | 1595275-62-9 |
Formula | C75H101N9O23 |
MW | 1496.65 |
Appearance | White to light yellow powder |
Storage condition | Avoid light, nitrogen, -20 ℃ |
Size | Availability | Price(USD) | VIP Price (USD) | Quantity |
---|---|---|---|---|
1 mg | 3-5days | $5266.00 | Visible after login | |
5 mg | 3-5days | $11590.00 | Visible after login |
Product Name | Tesirine | SG3249 |
---|---|
CAS | 1595275-62-9 |
Formula | C75H101N9O23 |
MW | 1496.65 |
Appearance | White to light yellow powder |
Storage condition | Avoid light, nitrogen, -20 ℃ |
Tesirine (SG-3249; SG3249), cathepsin B-cleavable valine-alanine pyrrolobenzodiazepine (PBD) dimer used as an antibody-drug conjugate (ADC) payload; Tesirine was designed to combine the potent antitumor activity with desirable physicochemical properties such as favorable hydrophobicity and improved conjugation characteristics. Rovalpituzumab tesirine is a first-in-class ADC directed against delta-like protein 3 (DLL3), a novel target identified in tumour-initiating cells and expressed in small-cell lung cancer.
PMID: 27882195 PMCID: PMC5108040 DOI: 10.1021/acsmedchemlett.6b00062
PMID: 29992976 PMCID: PMC6041317 DOI: 10.1038/s41598-018-28533-4